While DSM's high scale-up related costs of powder manufacturing reduced our share of profits in the year, it is pleasing to note that a reduction in production costs for Fruitflow® powder was realised after the close of the financial year. Having capacity in place for the powder format is a strategically important milestone, and we continue to work closely with DSM to explore all avenues for growing revenues for our novel technology.
The number of international brands containing Fruitflow® continues to steadily increase, with a further 10 consumer brands launched in the year. Over 27 regional consumer brands worldwide have now been launched, and an increasing number of further commercial projects have been initiated with prospective customers.
With DSM making good progress in the marketplace it remains our belief that products addressing blood flow and circulation issues represent a long-term opportunity in the functional food sector. With the Company's very low operational costs we are well positioned to drive value for shareholders, and we remain positive about the outlook for the Fruitflow® business.
Growth should be rapid if you are right. If it's not rapid then you will be wrong. So lets give it a month and you will see whether you get the rapid growth as you expect or another set of dismal results as i expect. Ive told you what i expect and you will be able to refer to them as the results arrive. What do you expect the 6 month income to be?
Well i would not say the rise of metro Metro Manila is rapid, but i agree more people have money now then 10 years ago, but they spend there money on other things and are not that sold into supplements yet. Don't forget the filipino diet is made up of wholesome foods - fresh fruit and vegetables, fish, rice, fresh meat so reliance on supplements is not a priority. And yes the population is massive but there are over 7000 islands in the Philippines and the concentration of wealth would be concentrated to a few areas on the mainland, so the target audience is not really that big.
Your words "Lets see just a month to wait. But growth should be rapid now as the initial setup phase has passed so you should get a good idea of what ff is actually going to bring in."
Is that so very different from Colbaltblue's ?
Any income that reduces usage of existing funds is welcome, the multiples period on period are quite easy to do, but I won't.
I do find it funny, I read on the other site the most bizarre piece of criticism of me using facts being regarded as off the scale ramping, but in the SAME POST the most blatant ramping seen in many a moon, advising potentials to wait until 3p as the revenues flow in earnest. Hilarious, the biter bitten.
If you care to contact Moneyweek then, they ran an article a couple of weeks back covering the rapid rise of middle class consumerism across the whole area Malaysia, Indonesia and Phillipines. The total population is massive. So easy to work of preconceptions. Also AIM cover much much more territory than that. All there on their site, or FB pages.
"In brief, my view is that Provexis will succeed and income will rapidly accumulate to easily cover the £250k annual running costs" to say rapid would surely mean in the next year or 2. Clearly not the current financial year as they have already stated another loss will happen this year. Forget last year and percentages. They need to be posting £50k plus income to make breakeven next year at all likely. IMO they wont. Lets see just a month to wait. But growth should be rapid now as the initial setup phase has passed so you should get a good idea of what ff is actually going to bring in.
Good of you to answer on behalf of puk, I never treat any share as a quick buck and like I said I'm here regardless, top heavy admittedly, but this is only one involvement, ok let's not say save people, "deter" folk. If that's not the agenda, then what is ?
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.